Anika's Strategic Move: Sale of Arthrosurface Business
Deal News | Nov 07, 2024 | Goodwin
Anika Therapeutics, Inc., a leading global joint preservation company, has divested its Arthrosurface business in line with a strategic review to focus on high-potential orthopedic sectors such as Osteoarthritis Pain Management, Regenerative Solutions, and Sports Medicine. The company received a consideration of $10 million, which includes a non-interest-bearing promissory note for $7 million and up to $3 million additional consideration, contingent on the sales performance of Arthrosurface. The global operations of Anika are headquartered in Massachusetts, USA, and Goodwin's Life Sciences team advised on the transaction.
Sectors
- Healthcare
- Medical Devices
- Legal Services
Geography
- United States – Anika Therapeutics' global operations are headquartered just outside of Boston, Massachusetts.
Industry
- Healthcare – Anika Therapeutics operates within the healthcare sector, focusing on joint preservation and orthopedic care.
- Medical Devices – The sale of the Arthrosurface business, involved in orthopedic solutions, falls within the medical devices industry.
- Legal Services – Goodwin provided legal advisory services, an essential role in the transaction.
Financials
- $10 million – Total consideration for the sale of Arthrosurface, including a $7 million promissory note and up to $3 million based on performance.
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| Anika Therapeutics, Inc. | Target | Company | A global joint preservation company focused on orthopedic care. |
| Arthrosurface | Divested business | Company | A business unit sold by Anika, involved in orthopedic solutions. |
| Goodwin | Legal Advisor | Company | Provided legal advisory services for the transaction. |